CPEX Pharmaceuticals, Inc. (CPEX) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 104 transactions totaling $5.0M, demonstrating a bearish sentiment with -$753.7K in net insider flow. The most recent transaction on Apr 5, 2011 involved a transaction of 4,000 shares valued at $0.
No significant insider buying has been recorded for CPEX in the recent period.
No significant insider selling has been recorded for CPEX in the recent period.
Based on recent SEC filings, insider sentiment for CPEX is bearish with an Insider Alignment Score of 42/100 and a net flow of -$753.7K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CPEX Pharmaceuticals, Inc. (CPEX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading CPEX stock, having executed 104 transactions in the past 90 days. The most active insider is Horse Capital Qp L. P. Black (Executive), who has made 12 transactions totaling $2.6M.
Get notified when executives and directors at CPEX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 5, 2011 | Mcgovern Michael | Executive | Disposition | 4,000 | $N/A | $0 | |
| Apr 5, 2011 | Mcgovern Michael | Executive | Disposition | 10,000 | $N/A | $0 | |
| Apr 5, 2011 | Mcgovern Michael | Executive | Disposition | 355,137 | $N/A | $0 | |
| Apr 5, 2011 | W. Spiegel John | Executive | Disposition | 1,500 | $N/A | $0 | |
| Apr 5, 2011 | W. Spiegel John | Executive | Disposition | 5,600 | $N/A | $0 | |
| Apr 5, 2011 | Forrester Robert | Executive | Disposition | 3,000 | $N/A | $0 | |
| Apr 5, 2011 | R. Murphy James | Executive | Disposition | 7,000 | $N/A | $0 | |
| Apr 5, 2011 | R. Murphy James | Executive | Disposition | 117,168 | $N/A | $0 | |
| Apr 5, 2011 | P. Hebert Robert | Executive | Option Exercise | 65,205 | $N/A | $0 | |
| Apr 5, 2011 | P. Hebert Robert | Executive | Payment | 39,668 | $27.25 | $1.1M | Large |
| Apr 5, 2011 | P. Hebert Robert | Executive | Disposition | 33,515 | $N/A | $0 | |
| Apr 5, 2011 | A. Sedor John | Executive | Disposition | 1,200 | $N/A | $0 | |
| Apr 5, 2011 | A. Sedor John | Executive | Option Exercise | 146,875 | $N/A | $0 | |
| Apr 5, 2011 | A. Sedor John | Executive | Payment | 80,895 | $27.25 | $2.2M | Large |
| Apr 5, 2011 | A. Sedor John | Executive | Disposition | 84,627 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Payment(F) | 4 | $3.9M | 39.0% |
Sale(S) | 8 | $2.9M | 28.8% |
Purchase(P) | 46 | $2.1M | 21.3% |
Exercise(M) | 30 | $1.1M | 11.0% |
Disposition(D) | 13 | $0 | 0.0% |
Award(A) | 3 | $0 | 0.0% |
Insider activity at CPEX Pharmaceuticals, Inc. shows mixed signals across all time. While $2.1M in purchases indicates some executive confidence,$2.9M in sales balances the picture, resulting in a modest net flow of -$753.7K.17 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Horse Capital Qp L. P. Black, has transacted $2.6M during this period.